SPEX - Spherix Incorporated

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.08
+0.02 (+1.89%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close1.06
Open1.06
Bid0.90 x 200
Ask0.00 x 0
Day's Range1.06 - 1.15
52 Week Range0.89 - 4.75
Volume169,838
Avg. Volume558,877
Market Cap9.198M
Beta-1.40
PE Ratio (TTM)N/A
EPS (TTM)-0.60
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date1980-05-12
1y Target Est19.00
Trade prices are not sourced from all markets
  • Spherix Highlights Size of Multi-Billion Dollar Mobile Messaging Sector
    PR Newswire9 days ago

    Spherix Highlights Size of Multi-Billion Dollar Mobile Messaging Sector

    Company Details New Opportunities Following DatChat Acquisition NEW YORK , April 11, 2018 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) a technology company committed to advancing innovation by participation ...

  • Spherix Issues Letter to Shareholders
    PR Newswire16 days ago

    Spherix Issues Letter to Shareholders

    One of the driving forces of our Company is our pursuit of business strategies and investments that stand to benefit from both the rapid pace of technological change and ever changing complexities of consumer behavior. Spherix's proposed merger with DatChat provides a working solution to the growing privacy problem.

  • Spherix Expands Blockchain Investment
    PR Newswire24 days ago

    Spherix Expands Blockchain Investment

    NEW YORK, March 27, 2018 /PRNewswire/ -- Spherix Incorporated (SPEX) announced today that the Company has closed an investment in TheBit Daily LLC ("TheBit"), a development stage media and education platform focused on the blockchain and cryptocurrency space.  The site provides strategic and intelligently condensed insight to this exciting technology.  For more information, please visit: www.thebitdaily.com. TheBit Daily aims to lower the barrier of entry into the blockchain and cryptocurrency technology fields.  TheBit informs readers, who range from beginners to experts, through its easy to understand "Guides" on the main concepts behind blockchain and cryptocurrencies.  TheBit offers a free custom-curated newsletter that apprises users on the latest updates and events impacting the blockchain and cryptocurrencies sectors.

  • With A -118.45% Earnings Drop, Is Spherix Incorporated’s (NASDAQ:SPEX) A Concern?
    Simply Wall St.28 days ago

    With A -118.45% Earnings Drop, Is Spherix Incorporated’s (NASDAQ:SPEX) A Concern?

    Improvement in profitability and outperformance against the industry can be important characteristics in a stock for some investors. Below, I will assess Spherix Incorporated’s (NASDAQ:SPEX) track record on a highRead More...

  • PR Newswirelast month

    DatChat Issues Shareholder Update on Spherix Merger and Blockchain Development.

    NEW BRUNSWICK, N.J., March 19, 2018 /PRNewswire/ -- DatChat Incorporated ("DatChat"), an encrypted personal privacy platform, focused on encrypted communication, internet privacy and digital rights management, today updated shareholders on its merger agreement with Spherix Incorporated (SPEX), its continued blockchain development and mining efforts. This technology is in the development stage.

  • Spherix Announces Pricing of $3 Million Public Offering of Common Stock
    PR Newswirelast month

    Spherix Announces Pricing of $3 Million Public Offering of Common Stock

    NEW YORK, March 15, 2018 /PRNewswire/ -- Spherix Incorporated (SPEX), a technology development company committed to the fostering of innovation and monetization of intellectual property, today announced that it has priced a registered public offering on a "best efforts" basis of an aggregate of 2,222,222 shares of common stock at a price to the public of $1.35 per share.  The offering is expected to close on or about March 19, 2018, subject to the satisfaction of customary closing conditions. The aggregate gross proceeds of the offering are anticipated to be approximately $3 million.  After deducting the placement agent's commission and other estimated offering expenses payable by Spherix, the net proceeds to Spherix are anticipated to be approximately $2.7 million.  Spherix intends to use the net proceeds from the offering for working capital and general corporate purposes.

  • ACCESSWIRElast month

    Blog Exposure - Spherix Announces Acquisition of DatChat

    Stock Monitor: Performant Financial Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 15, 2018 / Active-Investors.com has just released a free research report on Spherix Inc. (NASDAQ: SPEX ). If ...

  • Spherix Announces Proposed Public Offering of Common Stock
    PR Newswirelast month

    Spherix Announces Proposed Public Offering of Common Stock

    NEW YORK, March 14, 2018 /PRNewswire/ -- Spherix Incorporated (SPEX), a technology development company committed to the fostering of innovation and monetization of intellectual property, today announced a proposed registered public offering of its common stock. The offering is being made on a "best efforts" basis and subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Laidlaw & Company (UK) Ltd. is acting as exclusive placement agent for the offering.

  • Spherix To Enter Cyber Security Market via DatChat Acquisition
    PR Newswirelast month

    Spherix To Enter Cyber Security Market via DatChat Acquisition

    NEW YORK, March 13, 2018 /PRNewswire/ -- Spherix Incorporated (SPEX) a technology development company committed to the fostering of innovation and monetization of intellectual property, today announced that it has entered into a definitive purchase agreement to acquire 100% ownership of DatChat Inc. DatChat is a privately held personal privacy platform, focused on Encrypted Communication, Internet Security and Digital Rights Management. Additionally, the Company is expanding its platform to include a peer-to-peer secure email system that will be built on Ethereum blockchain technology.

  • Hoth Therapeutics Inc. Announces Completion of Series A Financing
    PR Newswire2 months ago

    Hoth Therapeutics Inc. Announces Completion of Series A Financing

    NEW YORK, Feb. 22, 2018 /PRNewswire/ -- Hoth Therapeutics Inc. ("Hoth" or the "Company"), a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema, announced today that it has completed its Series A financing totaling $3 million, before expenses, to fund operations and advance Hoth's BioLexa Platform.  Laidlaw & Co (UK) Ltd. ("Laidlaw") in New York served as the sole placement agent.

  • Spherix Holds Annual Shareholder Meeting
    PR Newswire4 months ago

    Spherix Holds Annual Shareholder Meeting

    Announces Intent to Distribute Stock Dividend in 2018 NEW YORK , Dec. 13, 2017 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) a technology development company committed to the fostering of innovative ...

  • PR Newswire5 months ago

    Hoth Therapeutics Inc. Announces Issuance of First U.S. Patent on Its BioLexa Platform

    Patent Covers Proprietary Compositions for Eczema Treatment NEW YORK , Dec. 4, 2017 /PRNewswire/ -- Hoth Therapeutics Inc. ("Hoth" or the "Company"), a development stage biopharmaceutical ...

  • Have Investors Already Priced In Service Growth For Spherix Incorporated (SPEX)?
    Simply Wall St.5 months ago

    Have Investors Already Priced In Service Growth For Spherix Incorporated (SPEX)?

    Spherix Incorporated (NASDAQ:SPEX), a USD$8.42M small-cap, is a professional services company operating in an industry, which generally follows the ups and downs of the economic cycle, as its services caterRead More...

  • Spherix Announces Sponsorship of Student-Led Artificial Intelligence and Super Computing Initiative
    PR Newswire5 months ago

    Spherix Announces Sponsorship of Student-Led Artificial Intelligence and Super Computing Initiative

    NEW YORK, Nov. 8, 2017 /PRNewswire/ -- Spherix Incorporated ("Spherix" or the "Company") (SPEX), a technology development company committed to the fostering of innovative ideas, today announced the sponsorship of the Shark Tank initiative at the College of William & Mary in Virginia.  William & Mary is a cutting-edge research university and is the second-oldest institution of higher education in the United States.

  • Spherix Incorporated (SPEX): Time For A Financial Health Check
    Simply Wall St.6 months ago

    Spherix Incorporated (SPEX): Time For A Financial Health Check

    Spherix Incorporated (NASDAQ:SPEX) is a small-cap stock with a market capitalization of USD $8.35M. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, theyRead More...

  • PR Newswire6 months ago

    Hoth Therapeutics Inc. Announces the Addition of Dr. Richard D Granstein, M.D. to the Company's Technology Advisory Board

    NEW YORK, Oct. 16, 2017 /PRNewswire/ -- Hoth Therapeutics Inc., a Nevada corporation ("Hoth" or  the "Company"), a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema, announced today the addition of Dr. Richard D. Granstein, M.D., to the Company's Technology Advisory Board.  The Technology Advisory Board was formed to assist the Company in developing the BioLexa Platform.  The BioLexa Platform is a proprietary, patented, drug compound platform developed at the University of Cincinnati.

  • PR Newswire7 months ago

    Hoth Therapeutics Inc. Announces the Addition of Dr. Andrew Herr to the Company's Technology Advisory Board

    NEW YORK, Sept. 5, 2017 /PRNewswire/ -- Hoth Therapeutics Inc., a Nevada corporation ("Hoth" or the "Company"), a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema, announced today the addition of Dr. Andrew Herr, PhD, to the Company's Technology Advisory Board.  The Technology Advisory Board was formed to assist the Company in developing the BioLexa Platform.  The BioLexa Platform is a proprietary, patented, drug compound platform developed at the University of Cincinnati.

  • Spherix Announces the Addition of Dr. Scott T. Tagawa to Company's Technology Advisory Board
    PR Newswire8 months ago

    Spherix Announces the Addition of Dr. Scott T. Tagawa to Company's Technology Advisory Board

    NEW YORK, Aug. 15, 2017 /PRNewswire/ -- Spherix Incorporated ("Spherix" or the "Company") (SPEX), an intellectual property development company committed to the fostering of technology, today announced the addition of Dr. Scott T. Tagawa to the Company's Technology Advisory Board.  The Technology Advisory Board was formed to assist the Company in evaluating potential opportunities in the biopharmaceutical arena. Dr. Scott T. Tagawa, MD, MS is the Richard A. Stratton Associate Professor in Hematology and Oncology and an Associate Professor of Clinical Medicine and of Clinical Urology at Weill Cornell Medicine.

  • Spherix Issues Letter to Shareholders
    PR Newswire9 months ago

    Spherix Issues Letter to Shareholders

    NEW YORK, Aug. 2, 2017 /PRNewswire/ -- Spherix Incorporated (SPEX) an intellectual property development company committed to fostering of technology, today issued a letter to shareholders. It is with great pleasure that I take this opportunity to update you on recent events at the Company and describe in greater detail our strategic path forward.   The fundamentals at Spherix are stronger than they have been in recent memory and our path to value creation is moving forward with precision and focus.

  • Spherix Announces That Anthony Hayes Joins the Board of Directors at Hoth Therapeutics Inc.
    PR Newswire9 months ago

    Spherix Announces That Anthony Hayes Joins the Board of Directors at Hoth Therapeutics Inc.

    NEW YORK, July 27, 2017 /PRNewswire/ -- Spherix Incorporated ("Spherix" or the "Company") (SPEX), an intellectual property development company committed to fostering of technology, today announced that Anthony Hayes, CEO of Spherix Inc., joins the board of directors at Hoth Therapeutics Inc.

  • Spherix Announces the Formation of a Technology Advisory Board in Area of BioPharmaceutical Opportunities
    PR Newswire9 months ago

    Spherix Announces the Formation of a Technology Advisory Board in Area of BioPharmaceutical Opportunities

    NEW YORK, July 25, 2017 /PRNewswire/ -- Spherix Incorporated ("Spherix" or the "Company") (SPEX), an intellectual property development company committed to the fostering of technology, today announced the formation of a Technology Advisory Board in the area of biopharmaceutical opportunities. The Technology Advisory Board was formed to assist the Company in evaluating potential opportunities in the biopharmaceutical arena, as well as to advise the Company in its work with Hoth Therapeutics. As previously reported, the Company recently acquired a controlling interest in Hoth Therapeutics, a company involved in the development of a novel topical treatment for patients suffering from atopic dermatitis, such as eczema.  Individuals serving on the advisory board will provide the Company advice, support and technical assistance in reviewing diversification opportunities.

  • Spherix Announces Closing Of Public Offering Of Common Stock
    PR Newswire9 months ago

    Spherix Announces Closing Of Public Offering Of Common Stock

    NEW YORK, July 24, 2017 /PRNewswire/ -- Spherix Incorporated ("Spherix" or the "Company") (SPEX), an intellectual property development company committed to fostering of technology, today announced that it has closed its previously announced firm commitment underwritten public offering of 1,250,000 shares of its common stock at a price to the public of $2.00 per share. After deducting the underwriter's discount and other offering expenses payable by Spherix, the net proceeds to the Company are approximately $2.1 million.

  • Spherix Announces Pricing of Public Offering of Common Stock
    PR Newswire9 months ago

    Spherix Announces Pricing of Public Offering of Common Stock

    NEW YORK, July 19, 2017 /PRNewswire/ -- Spherix Incorporated ("Spherix" or the "Company") (SPEX), an intellectual property development company committed to fostering of technology and monetization of intellectual property, today announced that it has priced a firm commitment underwritten public offering of 1,250,000 shares of its common stock at a price to the public of $2.00 per share. In addition, Spherix has granted the underwriter a 45-day option to purchase up to 187,500 additional shares of common stock to cover over-allotments, if any.

  • Spherix Inc. Announces Closing of the Deal with Hoth Therapeutics
    PR Newswire10 months ago

    Spherix Inc. Announces Closing of the Deal with Hoth Therapeutics

    Spherix Incorporated Acquires 6,800,000 shares of Hoth Therapeutics NEW YORK , July 3, 2017 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) reported today, following the disclosure made June 20 th ...

  • PR Newswire10 months ago

    Spherix Issues Letter to Shareholders

    NEW YORK, June 27, 2017 /PRNewswire/ -- Spherix Incorporated (SPEX) an intellectual property development company committed to the fostering of technology and monetization of intellectual property, today issued a letter to shareholders. With that in mind, I'm going to provide you with more information on the transaction and update you on why we believe this transaction has positioned Spherix for growth.  I want each of you to know that I see the fundamentals at Spherix stronger than at any time in the last few years and our path to value creation is moving forward with focus.